Cite
HARVARD Citation
Ihata, A. et al. (n.d.). FRI0104 Cohort study of infectious disease risk management in RA patients receiving tocilizumab at 48 weeks (ACT4U-study48). Annals of the rheumatic diseases. pp. 344-345. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ihata, A. et al. (n.d.). FRI0104 Cohort study of infectious disease risk management in RA patients receiving tocilizumab at 48 weeks (ACT4U-study48). Annals of the rheumatic diseases. pp. 344-345. [Online].